Viewing Study NCT00353366


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-02-24 @ 8:25 AM
Study NCT ID: NCT00353366
Status: COMPLETED
Last Update Posted: 2021-03-16
First Post: 2006-07-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
Sponsor: GlaxoSmithKline
Organization: